Management of strictures related to pancreaticobiliary disease continues to be an area of exploration and opportunity for treating both malignant and benign disease. Dilation and stenting of strictures helps patients maintain nutrition often while undergoing neoadjuvent treatment. This web page is intended to provide an venue to share clinical data, case studies and perspectives on biliary stenting from experts in the field to educate other physicians interested in advanced pancreaticobiliary disease management.
Presentations on Biliary Stricture Management
Dr. Costamagna and Dr. Bruno discuss the one-year and three-year results of a large, multi-center trial to assess the efficacy of using fully covered metal stents in benign biliary strictures due to chronic pancreatitis.
Five Gastroenterologists discuss their experiences treating strictures due to chronic pancreatitis, including the effectiveness of fully covered biliary metal stents.
In this presentation, Dr. Christer Staël von Holstein discusses various types of treatment for benign esophageal strictures, including dilation and stenting options.
Dr. Paul Tarnasky presents an overview of benign biliary strictures due to chronic pancreatitis as well as treatment options and clinical data.
Set-up and Use Tutorials
This video provides a step-by-step tutorial on the set up and deployment of the Epic Biliary Stent System.
The CRE SteriFlate Disposable Inflation Device is designed to inflate and deflate balloon dilatation catheters while monitoring and displaying inflation pressure. This video provides a step-by-step tutorial for the set-up and use of the inflation device.
The Alliance II Integrated Inflation & Lithotripsy Device is used to inflate balloon dilatation catheters. This video provides a step-by-step tutorial for the set-up and use of the inflation device.
Patient History The patient was a 75 year old woman diagnosed with cholangiocarcinoma in the CBD 1-1/2 years prior.
Dr. Kowalski provides a step-by-step demonstration of set-up and deployment of a WallFlex Biliary RX Stent.
This animation highlights the features of the Advanix Biliary Stent with NaviFlex™ RX Delivery System as well as the steps for placement and deployment.
Warning: The safety and effectiveness of biliary metal stents for use in the vascular system has not been established.
Results from case studies may vary. Results from case studies are not predictive of results in other case studies.
INDICATIONS FOR USE in the United States:
The WallFlex Biliary RX Fully Covered Stent System RMV is indicated for use in the palliative treatment of biliary strictures produced by malignant neoplasms, relief of malignant biliary obstruction prior to surgery and for indwell up to 12 months in the treatment of benign biliary strictures secondary to chronic pancreatitis.
The sale, distribution, and use of the device are restricted to prescription use inaccordance with 21 CFR §801.109
• The WallFlex Biliary RX Fully Covered Stent should not be placed in strictures that cannot be dilated enough to pass the delivery system, in a perforated duct, or in very small intrahepatic ducts.
• The WallFlex Biliary RX Fully Covered Stent System RMV should not be used in patients for whom endoscopic techniques are contraindicated.
Warnings: The safety and effectiveness of the stent has not been established for indwell periods exceeding 12 months. The WallFlex Biliary RX Fully Covered Stent System RMV is for single-use only. The safety and effectiveness of the WallFlex Biliary RX Fully Covered Stent System RMV for use in the vascular system has not been established. The safety and effectiveness of the WallFlex Biliary RX Fully Covered Stent System RMV has not been established in the treatment of benign biliary anastomotic strictures in liver transplant patients and benign biliary post abdominal surgery strictures. Testing of overlapped stents has not been conducted. The stent contains nickel, which may cause an allergic reaction in individuals with nickel sensitivity.
PLEASE REFER TO THE LABELING FOR A MORE COMPLETE LIST OF WARNINGS, PRECAUTIONS AND CONTRAINDICATIONS
ACCESS Magazine Clinical Data Update